Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

7.00
Delayed Data
As of Aug 28
 +0.22 / +3.24%
Today’s Change
3.05
Today|||52-Week Range
8.61
-12.61%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close6.78
Today’s open6.69
Day’s range6.69 - 7.13
Volume272,339
Average volume (3 months)314,187
Market cap$271.3M
Dividend yield--
Data as of 08/28/2015

Growth & Valuation

Earnings growth (last year)+66.94%
Earnings growth (this year)-176.59%
Earnings growth (next 5 years)--
Revenue growth (last year)+53.16%
P/E ratio--
Price/Sales6.09
Price/Book2.94

Competitors

 Today’s
change
Today’s
% change
RIGLRigel Pharmaceutical...+0.12+4.18%
NATRNatures Sunshine Pro...+0.15+1.26%
NUTRNutraceutical Intern...0.000.00%
CDTXCidara Therapeutics ...+0.23+1.59%
Data as of 08/28/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$46.9M
Annual profit (last year)-$14.6M
Net profit margin-31.20%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts

Chart unavailable

Partner Offers